Changming Xia

4PUBLICATIONS
26CO-AUTHORS
Infant and child healthPharmacogenomicsEpidemiological methodsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 10, 2026
Dupilumab Improves Endoscopic Features in Children Aged 1-11 Years With Eosinophilic Esophagitis: EoE KIDS Study Results.

|Aug 06, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma.

William W Busse, Monica Kraft, Christian Domingo

|Feb 05, 2025
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial.

Albert J Bredenoord, Evan S Dellon, Christoph Schlag

|Jun 11, 2024
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.

Nijra L Lugogo, Enrico Heffler, Vicente Plaza

Pageof 1

Frequent Collaborators

3 joint publications

Juby A Jacob-Nara

2 joint publications

Nami Pandit-Abid

1 joint publications

Nijra L Lugogo

1 joint publications

Enrico Heffler